• 1
    Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med 1997; 126:6373.
  • 2
    Marcus FI, Opie LH. Antiarrhythmic agents. In: OpieLH, ed. Drugs for the Heart, 4th ed. Philadelphia , PA : WB Saunders; 1995: 207247.
  • 3
    Brien JF, Jimmo S, Brennan FJ, et al. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens. Drug Me-tab Dispos 1990;18:846.
  • 4
    Lewis JH, Mullick F, Ishak KG, et al. Histopathologic analysis of suspected amiodarone hepatotoxicity. Hum Pathol 1990;21:5967.
  • 5
    Fromenty B, Pessayre D. Impaired mitochondrial function in mi-crovesicular steatosis. Effects of drugs, ethanol, hormones and cyto-kines. J Hepatol 1997;26:4353.
  • 6
    Rotmensch HH, Belhassen B, Swanson BN, et al. Steady-state serum amiodarone concentrations: Relationships with antiarrhythmic efficacy and toxicity. Ann Intern Med 1984;101:462466.
  • 7
    Tisdale JE, Follin SL, Ordelova A, et al. Risk factors for the development of specific noncardiovascular adverse effects associated with amiodarone. J Clin Pharmacol 1995;35:351356.
  • 8
    Josephson SA, Kessel ER. Amiodarone hepatotoxicity. Dig Dis 1997;15:312.
  • 9
    Adams PC, Gibson GJ, Morley AR, et al. Amiodarone pulmonary toxicity: Clinical and subclinical features. Q J Med 1986;59:449471.
  • 10
    Snir Y, Pick N, Riesenberg K, et al. Fatal hepatic failure due to prolonged amiodarone treatment. J Clin Gastroenterol 1995;20:265266.
  • 11
    Breuh HW, Bossek W, Hafeland C, et al. Amiodarone induced severe hepatitis mediated by immunological mechanisms. Int J Clin Pharmacol Ther 1998;36:350352.
  • 12
    D'Amico DJ, Kenyon KR, Ruskin JN. Amiodarone keratopa-thy: Drug-induced lipid storage disease. Arch Ophthalmol 1981;99:257261.
  • 13
    Wright AJ, Brackenridge RG. Pulmonary infiltration and bone marrow depression complicating treatment with amiodarone. Br Med J 1982;284:1303.
  • 14
    Kittleson MD. Drugs used in treatment of cardiac arrhythmias. In: KittlesonMD, KienleRD, eds. Small Animal Cardiovascular Medicine. St Louis , MO : Mosby Inc; 1998: 504.
  • 15
    Calvert CA. Diagnosis and management of ventricular arrhythmias in Doberman Pinschers with cardiomyopathy. In: BonaguraJD, ed. Kirk's Current Veterinary Therapy, XII: Small Animal Practice. Philadelphia , PA : WB Saunders; 1995.
  • 16
    Calvert CA, Hall G, Jacobs GJ, et al. Clinical and pathologic findings in Doberman Pinschers with occult cardiomyopathy that died suddenly or developed congestive heart failure. J Am Vet Med Assoc 1997;210:505511.
  • 17
    Crawford MA, Schall WD, Jensen RK, Tasker JB. Chronic active hepatitis in 26 Doberman Pinschers. J Am Vet Med Assoc 1985; 187:13431349.
  • 18
    Bunch SE. Hepatotoxicity associated with pharmacologic agents in dogs and cats. Vet Clin North Am 1993;23:659670.